Abivax: Latest Obefazimod Data Eases Safety Fears, Brings M&A Back Into Play

πŸ‡ΊπŸ‡Έ Seeking Alpha (US) —
Abivax: Latest Obefazimod Data Eases Safety Fears, Brings M&A Back Into Play

AI Summary

Abivax reported new safety data on Obefazimod that alleviated previous concerns and rekindled interest in potential mergers and acquisitions involving the company. The development has implications for its valuation and strategic transactions.

Markets Deals Health Abivax Obefazimod safety data M&A biopharma clinical data

Read original source →